Considering these results in conjunction with a study where increased serum levels of HIF-1α seen in severe OSA patients were decreased after two months of continuous positive air pressure (CPAP) therapy [25], treating hypoxia may be a putative treatment method for metabolic syndrome via the HIF-1α pathway. This evidence concerns the gene HIF1A and obstructive sleep apnea syndrome.